 |
|
You are here: Foswiki>Main Web>WikiUsers>CataliesWw (12 Dec 2023, CataliesWw)Edit Attach
The application of CrossMab technology in cancer treatment is to use bispecific or multispecific antibodies to target tumor-related targets, thereby achieving anti-tumor and immune modulation effects. There are many bispecific antibodies developed using CrossMab technology targeting tumor-related targets,such as VEGF, Ang-2, FAP, CD20, CD3.
UserForm edit
| FirstName | Catalina |
| LastName | Garcia |
| OrganisationName | |
| OrganisationURL | |
| Profession | |
| Country | |
| State | |
| Address | |
| Location | |
| Telephone | |
| VoIP | |
| InstantMessaging (IM) | |
| HomePage | |
| Comment |
Edit | Attach | Print version | History: r2 < r1 | Backlinks | View wiki text | Edit wiki text | More topic actions
Topic revision: r2 - 12 Dec 2023, CataliesWw
Main
Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors. Ideas, requests, problems regarding Foswiki? Send feedback